PRRX1 and gastric cancer: The fact that PRRX1 promotes EMT through the Wnt/β-catenin pathway in gastric cancer [53] and that LGR5 is a co-receptor of the Wnt/β-catenin pathway involved in tumorigenesis clearly suggests an intimate association between PRRX1, LGR5 and EMT.